Unit
- First human lung transplant: Dr. James Hardy performed the first lung transplant at the University of Mississippi in 1963. The patient survived 18 days, dying from renal failure and rejection. This case exposed the need for effective immunosuppression and careful recipient selection.
- Early clinical attempts: Throughout the 1960s and 1970s, fewer than 40 lung transplants were attempted worldwide, with most recipients surviving only days to weeks. Technical challenges included airway healing, infection, and lack of reliable immunosuppressive agents.
- Cyclosporine breakthrough: The introduction of cyclosporine in the early 1980s revolutionized solid organ transplantation. For lung transplantation, cyclosporine reduced acute rejection rates and improved short-term survival, enabling the first successful long-term outcomes.
- First successful single-lung transplant: In 1983, Dr. Joel Cooper at the University of Toronto performed the first clinically successful single-lung transplant. The recipient survived over six years. This achievement proved that lung transplantation could be a viable therapy for end-stage lung disease.
- Double-lung transplant development: The first successful double-lung transplant was performed in 1988 by Dr. Alec Patterson at the same institution. Double-lung transplantation offered advantages for septic lung diseases like cystic fibrosis, improving infection control and overall outcomes.
- Evolution of immunosuppressive regimens: Since the 1990s, multidrug regimens including calcineurin inhibitors, antimetabolites, and corticosteroids have become standard. The introduction of tacrolimus and mycophenolate mofetil further improved graft survival and reduced side effects.
- ISHLT registry and outcomes tracking: The International Society for Heart and Lung Transplantation established a registry in the early 1990s. This registry has been instrumental in collecting data on survival, complications, and practice patterns, driving evidence-based improvements in transplant care.
- Modern advances and ex-vivo lung perfusion: Ex-vivo lung perfusion, developed in the 2000s, allows donor lungs to be assessed and reconditioned outside the body. This technology has expanded the donor pool and improved the quality of marginal organs, increasing transplant volumes.
- Ethical milestones: The development of ethical guidelines for organ allocation, informed consent, and living donation has paralleled surgical progress. The United Network for Organ Sharing oversees equitable distribution policies in the United States.
- Lung allocation score implementation: The lung allocation score was introduced by UNOS in 2005 to prioritize candidates based on medical urgency and post-transplant survival. This system replaced time-based waiting lists, reducing waitlist mortality and improving allocation efficiency for patients with the greatest need.
- Chronic lung allograft dysfunction: Bronchiolitis obliterans syndrome remains the leading cause of late death after lung transplantation. Understanding of its risk factors, diagnosis, and management has evolved significantly, leading to increased research into prevention strategies and novel therapies like azithromycin and extracorporeal photopheresis.
- Pediatric lung transplantation: Lung transplantation in children was pioneered in the late 1980s and early 1990s. Unique challenges include growth, developmental considerations, and higher rates of viral infections. Outcomes have improved with tailored immunosuppression and dedicated pediatric transplant programs.
Scope of Practice
Role: Transplant Coordinator
Within scope:
- Educating patients and families about transplant history and prognosis.
- Coordinating pre-transplant evaluation appointments and test results.
- Maintaining patient records and ensuring compliance with registry reporting.
- Facilitating communication between the transplant team and referring physicians.
- Assisting in obtaining informed consent for transplant procedures.
Outside scope:
- Prescribing immunosuppressive medications or adjusting drug dosages.
- Making surgical decisions about donor-recipient matching.
- Performing transplant surgery or donor organ procurement.
- Diagnosing acute rejection or interpreting biopsy results.
- Setting organ allocation policy or overriding UNOS rules.
Quick Revision
- Lung transplantation began with Hardy's 1963 attempt and became viable with cyclosporine in the 1980s.
- Cooper's 1983 single-lung transplant proved long-term success was possible.
- The ISHLT registry provides critical outcome data for evidence-based practice.
- Modern advances like EVLP have expanded the donor pool and improved graft quality.
- Transplant coordinators support the process but do not perform surgical or prescribing roles.